162 related articles for article (PubMed ID: 26643572)
21. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
22. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9.
Neville DM; Scharff J; Hu HZ; Rigaut K; Shiloach J; Slingerland W; Jonker M
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):85-92. PubMed ID: 8732691
[TBL] [Abstract][Full Text] [Related]
23. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro.
Vaclavkova P; Cao Y; Wu LK; Michalek J; Vitetta ES
Bone Marrow Transplant; 2006 Mar; 37(6):559-67. PubMed ID: 16444279
[TBL] [Abstract][Full Text] [Related]
24. Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas.
Remer M; Al-Shamkhani A; Glennie M; Johnson P
Immunotherapy; 2014; 6(11):1187-206. PubMed ID: 25496334
[TBL] [Abstract][Full Text] [Related]
25. Half depletion of Foxp3+ regulatory T cells by diphtheria toxin for long-term study in vivo.
Qiu X; Leung WT; Gober HJ; Li L; Zhang N; Chu N; Wang L
Biosci Trends; 2021 Jan; 14(6):460-462. PubMed ID: 33328393
[TBL] [Abstract][Full Text] [Related]
26. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.
Morse MA; Hobeika AC; Osada T; Serra D; Niedzwiecki D; Lyerly HK; Clay TM
Blood; 2008 Aug; 112(3):610-8. PubMed ID: 18519811
[TBL] [Abstract][Full Text] [Related]
27. Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.
Baatar D; Olkhanud P; Sumitomo K; Taub D; Gress R; Biragyn A
J Immunol; 2007 Apr; 178(8):4891-900. PubMed ID: 17404270
[TBL] [Abstract][Full Text] [Related]
28. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
[TBL] [Abstract][Full Text] [Related]
29. Depletion of human regulatory T cells.
Hobeika AC; Morse MA; Osada T; Peplinski S; Lyerly HK; Clay TM
Methods Mol Biol; 2011; 707():219-31. PubMed ID: 21287338
[TBL] [Abstract][Full Text] [Related]
30. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
Knutson KL; Dang Y; Lu H; Lukas J; Almand B; Gad E; Azeke E; Disis ML
J Immunol; 2006 Jul; 177(1):84-91. PubMed ID: 16785502
[TBL] [Abstract][Full Text] [Related]
31. Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.
Watanabe M; Kanao K; Suzuki S; Muramatsu H; Morinaga S; Kajikawa K; Kobayashi I; Nishikawa G; Kato Y; Zennami K; Nakamura K; Tsuzuki T; Yoshikawa K; Ueda R; Sumitomo M
Prostate; 2019 Oct; 79(14):1658-1665. PubMed ID: 31390096
[TBL] [Abstract][Full Text] [Related]
32. Transient Treg depletion enhances therapeutic anti-cancer vaccination.
Fisher SA; Aston WJ; Chee J; Khong A; Cleaver AL; Solin JN; Ma S; Lesterhuis WJ; Dick I; Holt RA; Creaney J; Boon L; Robinson B; Lake RA
Immun Inflamm Dis; 2017 Mar; 5(1):16-28. PubMed ID: 28250921
[TBL] [Abstract][Full Text] [Related]
33. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
Wang Z; Duran-Struuck R; Crepeau R; Matar A; Hanekamp I; Srinivasan S; Neville DM; Sachs DH; Huang CA
Bioconjug Chem; 2011 Oct; 22(10):2014-20. PubMed ID: 21866954
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells and regulatory T cells expressing CCR4 provide resistance to coxsackievirus B5-induced pancreatitis.
Françozo MCS; Costa FRC; Guerra-Gomes IC; Silva JS; Sesti-Costa R
Sci Rep; 2019 Oct; 9(1):14766. PubMed ID: 31611578
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
36. Tumors establish resistance to immunotherapy by regulating T
Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
[TBL] [Abstract][Full Text] [Related]
37. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
Christiaansen AF; Boggiatto PM; Varga SM
J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
[TBL] [Abstract][Full Text] [Related]
38. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9.
Huang CA; Yamada K; Murphy MC; Shimizu A; Colvin RB; Neville DM; Sachs DH
Transplantation; 1999 Sep; 68(6):855-60. PubMed ID: 10515387
[TBL] [Abstract][Full Text] [Related]
39. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
[TBL] [Abstract][Full Text] [Related]
40. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]